THUMB: Multi-centre Cluster Trial for Caesarean Section Haemorrhage
Launched by BRUCE BICCARD · Jun 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The THUMB trial is a study aimed at improving care for women who need a cesarean section, especially to prevent excessive bleeding, known as postpartum hemorrhage. Researchers want to see if a special set of guidelines, called the 'Rule of THUMB,' can help healthcare providers better assess risks, diagnose problems, and follow proven methods to manage bleeding during and after surgery. They will also look at how different factors, like the hospital environment and teamwork, affect how well these guidelines work in real-life situations. The goal is to make improvements that can be used in hospitals across Africa in the future.
To participate in this trial, women who are scheduled to have a cesarean section at one of the participating hospitals can join. However, if a patient chooses not to be part of the study, they will be excluded. While the study is not yet recruiting participants, women who take part can expect to help improve healthcare practices that could benefit many others in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Any patient who requires a caesarean section in participating countries with hospitals that routinely perform caesarean section.
- Exclusion Criteria:
- • Patients who opt out of the trial will be excluded.
About Bruce Biccard
Bruce Biccard is a distinguished clinical trial sponsor renowned for his commitment to advancing medical research and improving patient outcomes. With a strong background in anesthesiology and critical care, he leads initiatives that focus on innovative therapeutic approaches and evidence-based practices. His dedication to ethical standards and rigorous methodology ensures that clinical trials under his sponsorship are conducted with the highest levels of integrity and scientific rigor. Bruce Biccard's leadership not only fosters collaboration among multidisciplinary teams but also emphasizes the importance of patient safety and regulatory compliance in the pursuit of groundbreaking healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
BRUCE BICCARD, PhD
Principal Investigator
University of Cape Town
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported